U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C14H8ClNO4.2Na
Molecular Weight 335.65
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LOBENZARIT SODIUM

SMILES

[Na+].[Na+].[O-]C(=O)C1=C(NC2=C(C=CC(Cl)=C2)C([O-])=O)C=CC=C1

InChI

InChIKey=QPJBONAWFAURGB-UHFFFAOYSA-L
InChI=1S/C14H10ClNO4.2Na/c15-8-5-6-10(14(19)20)12(7-8)16-11-4-2-1-3-9(11)13(17)18;;/h1-7,16H,(H,17,18)(H,19,20);;/q;2*+1/p-2

HIDE SMILES / InChI

Molecular Formula C14H8ClNO4
Molecular Weight 289.671
Charge -2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Na
Molecular Weight 22.9898
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including: https://www.ncbi.nlm.nih.gov/pubmed/9161931 | http://www.rad-ar.or.jp/siori/english/kekka.cgi?n=750

Lobenzarit is an immunomodulator and antioxidative agent, which has been used successfully in Japan for the treatment of rheumatoid arthritis. Lobenzarit is a scavenger of oxygen-free radicals such as hydroxyl radicals, superoxide, peroxyl and singlet oxygen. Side effects of this medicine are: decreased/considerably increased urinary volume, bloody urine, frequent urination.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P00390
Gene ID: 2936.0
Gene Symbol: GSR
Target Organism: Homo sapiens (Human)
Target ID: Glutathione S-transferases (rat)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
CARFENIL

Approved Use

This medicine improves immune abnormality and reduces inflammation and swelling of joints and so on. It is usually used to treat chronic rheumatoid arthritis.

Launch Date

1986
PubMed

PubMed

TitleDatePubMed
Alpha-methyldopa-type autoimmune hemolytic anemia caused by lobenzarit disodium of a mefenamic acid derivative and immunomodulator.
1994 May 15
Application of a new mathematical method for the estimation of the mean surface area to calculate the percolation threshold of lobenzarit disodium [correction of dissodium] salt in controlled release matrices.
2004 Jul
Estimation of the percolation thresholds in ternary lobenzarit disodium-dextran-HPMC hydrophilic matrices tablets: effects of initial porosity.
2009 Nov 5
Patents

Sample Use Guides

2 tablets (80 mg of the active ingredient) at a time, 3 times a day, in combination with other antiphlogistic analgesic
Route of Administration: Oral
In Vitro Use Guide
The Iobenzarit at concentrations of 1, 30, 100 and 1000 uM Iobenzarit had no inhibitory effect on various rat liver microsomal P-450 activities: on the ethoxyresorufin O-dealkylation activity, on the pentoxyresorufin O-deaikylation activity or on the p-nitrophenol hydroxylation activity, when measured in liver microsomes isolated from rats induced with beta-naphthoflavone, phenobarbital and pyrazol.
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:55:23 GMT 2023
Edited
by admin
on Fri Dec 15 15:55:23 GMT 2023
Record UNII
7Z9SP74BXF
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LOBENZARIT SODIUM
MART.   USAN   WHO-DD  
USAN  
Official Name English
LOBENZARIT SODIUM [USAN]
Common Name English
LOBENZARIT DISODIUM SALT
MI  
Common Name English
LOBENZARIT DISODIUM
JAN  
Common Name English
BENZOIC ACID, 2-((2-CARBOXYPHENYL)AMINO)-4-CHLORO-, DISODIUM SALT
Common Name English
LOBENZARIT SODIUM [MART.]
Common Name English
CARFENIL
Brand Name English
LOBENZARIT SODIUM [JAN]
Common Name English
Lobenzarit sodium [WHO-DD]
Common Name English
DISODIUM 4-CHLORO-2,2'-IMINODIBENZOATE
Systematic Name English
LOBENZARIT DISODIUM SALT [MI]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C257
Created by admin on Fri Dec 15 15:55:23 GMT 2023 , Edited by admin on Fri Dec 15 15:55:23 GMT 2023
Code System Code Type Description
MERCK INDEX
m6880
Created by admin on Fri Dec 15 15:55:23 GMT 2023 , Edited by admin on Fri Dec 15 15:55:23 GMT 2023
PRIMARY Merck Index
CAS
64808-48-6
Created by admin on Fri Dec 15 15:55:23 GMT 2023 , Edited by admin on Fri Dec 15 15:55:23 GMT 2023
PRIMARY
SMS_ID
100000086151
Created by admin on Fri Dec 15 15:55:23 GMT 2023 , Edited by admin on Fri Dec 15 15:55:23 GMT 2023
PRIMARY
FDA UNII
7Z9SP74BXF
Created by admin on Fri Dec 15 15:55:23 GMT 2023 , Edited by admin on Fri Dec 15 15:55:23 GMT 2023
PRIMARY
PUBCHEM
47462
Created by admin on Fri Dec 15 15:55:23 GMT 2023 , Edited by admin on Fri Dec 15 15:55:23 GMT 2023
PRIMARY
EVMPD
SUB02963MIG
Created by admin on Fri Dec 15 15:55:23 GMT 2023 , Edited by admin on Fri Dec 15 15:55:23 GMT 2023
PRIMARY
EPA CompTox
DTXSID8048606
Created by admin on Fri Dec 15 15:55:23 GMT 2023 , Edited by admin on Fri Dec 15 15:55:23 GMT 2023
PRIMARY
NCI_THESAURUS
C72817
Created by admin on Fri Dec 15 15:55:23 GMT 2023 , Edited by admin on Fri Dec 15 15:55:23 GMT 2023
PRIMARY
ChEMBL
CHEMBL1986706
Created by admin on Fri Dec 15 15:55:23 GMT 2023 , Edited by admin on Fri Dec 15 15:55:23 GMT 2023
PRIMARY
USAN
W-112
Created by admin on Fri Dec 15 15:55:23 GMT 2023 , Edited by admin on Fri Dec 15 15:55:23 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY